Comparison of DSM-IV-TR and DSM-5 for ASD
1 other identifier
observational
439
1 country
5
Brief Summary
The study aim is to prospectively compare DSM-IV-TR and DSM-5 criteria for Autism Spectrum Disorder (ASD) in a sample of 250 children and adolescents who meet DSM-IV-TR criteria for ASD and 150 children and adolescents referred for diagnosis who do not meet DSM-IV-TR criteria.Families and children will be recruited from eight sites affiliated with the Autism Treatment Network (ATN). Participants must be between the ages of 2.0 and 17.11 years who undergo an ATN assessment at one of the eight sites. Both subjects who are found to meet criteria of ASD/PDD and those who do not meet criteria (after completing the ATN assessment) will be enrolled. After completing the standard ATN assessment, clinicians will complete a DSM-IV and DSM-5 checklist for ASD/PDD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 18, 2014
CompletedFirst Posted
Study publicly available on registry
November 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedResults Posted
Study results publicly available
March 11, 2019
CompletedMarch 11, 2019
November 1, 2018
2 years
November 18, 2014
July 7, 2017
November 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical Features of Concordant vs Discordant Groups
Clinical Features of Concordant versus Discordant Groups. Full Scale IQ: Stanford-Binet IQ test.(score range 40-160; higher = greater intellectual abilties) ABC = Aberrant Behavior Checklist, which includes: Irritability subscale: score range 0-45, higher = more problems. Social Withdrawal subscale: score range 0-48, higher = more problems. Stereotypic Behavior subscale: score range 0-21, higher = more problems. Hyperactivity/Noncompliance subscale: score range 0-48, higher = more problems. Inappropriate Speech subscale: score range 0-12, higher = more problems. CBCL = Child Behavior Checklist, which includes: Externalizing Problems and Internalizing problems: T scores less than 60 are considered in the normal range, 60-63 represent borderline scores, and scores greater than 63 are in the clinical range
One day
Sensitivity and Specificity of DSM-5 Criteria for ASD Relative to DSM-IV Criteria
Sensitivity and Specificity of DSM-5 Criteria for ASD Relative to DSM-IV Criteria Sensitivity refers to the ability of the DSM-5 to correctly identify those with ASD, whereas specificity is the ability of the DSM-5 to correctly identify those without ASD.
day
Study Arms (4)
Autism Spectrum Disorder (DSM IV & 5)
All children and adolescents seen for autism diagnostic evaluations at the study sites who meet diagnostic criteria for ASD in both DSM-IV and DSM-5
Autism Spectrum Disorder (DSM 5 only)
All children and adolescents seen for autism diagnostic evaluations at the study sites who meet diagnostic criteria for ASD in DSM-5 but not DSM-IV
Autism Spectrum Disorder (DSM IV only)
All children and adolescents seen for autism diagnostic evaluations at the study sites who meet diagnostic criteria for ASD in DSM-IV but not DSM-5
Non-Autism Spectrum Disorder
All children and adolescents seen for autism diagnostic evaluations at the study sites who do not meet diagnostic criteria for ASD.
Interventions
Comparing use of DSM-IV versus DSM-5 criteria for autism spectrum disorder
Eligibility Criteria
All children ages 2-17 who are being evaluated for a possible diagnosis of autism spectrum disorder
You may qualify if:
- age 2-17
- question of possible autism spectrum disorder
You may not qualify if:
- \<2 years old \>17 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- University of Missouri-Columbiacollaborator
- Children's Hospital Los Angelescollaborator
- Nationwide Children's Hospitalcollaborator
- Children's Hospital Medical Center, Cincinnaticollaborator
- Vanderbilt Universitycollaborator
Study Sites (5)
Children's Hospital of Los Angeles
Los Angeles, California, 90027, United States
University of Missouri
Columbia, Missouri, 65201, United States
Children's Hospital of Cincinnati
Cincinnati, Ohio, 45229, United States
Nationwide Children's Hospital
Columbus, Ohio, 43081, United States
Vanderbilt University
Nashville, Tennessee, 37240, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Benjamin L Handen, PhD
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Handen, PhD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professof of Psychiatry
Study Record Dates
First Submitted
November 18, 2014
First Posted
November 20, 2014
Study Start
November 1, 2014
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
March 11, 2019
Results First Posted
March 11, 2019
Record last verified: 2018-11